Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hobart

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Pediatrics|June 15, 2025
Prescribing Assistive Technology: Focus on Children With Complex Communication Needs: Clinical ReportLarry W Desch, Laura J Hobart-Porter, Amy Houtrow, et al.
Annals of Human Genetics|February 1, 1981
Polymorphism of human c5M J Hobart, M A vaz Guedes, P J Lachmann
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|June 1, 1994
A novel human complement component C7 phenotype detected in South Africa and proposed designation of the allele as C7*10A Orren, R Würzner, P J Lachmann, et al.
Journal of Gerontology|January 1, 1990
Adult age group differences in story recall styleC Adams, G Labouvie-Vief, C J Hobart, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 20, 2001
High dose naltrexone for dyskinesias induced by levodopaA J Manson, R Katzenschlager, J Hobart, et al.
Brain : a Journal of Neurology|May 4, 2001
The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measureJ Hobart, D Lamping, R Fitzpatrick, et al.
Immunochemistry|April 1, 1976
Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activationA Martin, P J Lachmann, L Halbwachs, et al.
Journal of Immunogenetics|August 1, 1978
Absence of variation in human C5M A Vaz-Guedes, M J Hobart, P J Lachmann
Journal of Neurology, Neurosurgery, and Psychiatry|August 21, 2001
The SF-36 in multiple sclerosis: why basic assumptions must be testedJ Hobart, J Freeman, D Lamping, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2004
Stroke in Devon: knowledge was good, but action was poorC Carroll, J Hobart, C Fox, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Pediatrics|June 15, 2025
Prescribing Assistive Technology: Focus on Children With Complex Communication Needs: Clinical ReportLarry W Desch, Laura J Hobart-Porter, Amy Houtrow, et al.
Annals of Human Genetics|February 1, 1981
Polymorphism of human c5M J Hobart, M A vaz Guedes, P J Lachmann
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|June 1, 1994
A novel human complement component C7 phenotype detected in South Africa and proposed designation of the allele as C7*10A Orren, R Würzner, P J Lachmann, et al.
Journal of Gerontology|January 1, 1990
Adult age group differences in story recall styleC Adams, G Labouvie-Vief, C J Hobart, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 20, 2001
High dose naltrexone for dyskinesias induced by levodopaA J Manson, R Katzenschlager, J Hobart, et al.
Brain : a Journal of Neurology|May 4, 2001
The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measureJ Hobart, D Lamping, R Fitzpatrick, et al.
Immunochemistry|April 1, 1976
Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activationA Martin, P J Lachmann, L Halbwachs, et al.
Journal of Immunogenetics|August 1, 1978
Absence of variation in human C5M A Vaz-Guedes, M J Hobart, P J Lachmann
Journal of Neurology, Neurosurgery, and Psychiatry|August 21, 2001
The SF-36 in multiple sclerosis: why basic assumptions must be testedJ Hobart, J Freeman, D Lamping, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2004
Stroke in Devon: knowledge was good, but action was poorC Carroll, J Hobart, C Fox, et al.
Pageof 10